Congestion in Acute Heart Failure Syndromes: An Essential Target of Evaluation and Treatment

American Journal of Medicine

Volumn 119, Issue 12 SUPPL., 2006, Pages

  Gheorghiade, Mihai ^a   Filippatos, Gerasimos ^b   De Luca, Leonardo ^c   Burnett, John ^d  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^c EUROPEAN HOSPITAL   (Italy)

^d MAYO CLINIC   (United States)

Author keywords

Acute heart failure syndromes; Outcomes; Pulmonary congestion; Treatment

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; ANGIOTENSIN; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLITAZONE DERIVATIVE; LOOP DIURETIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL ANTIDIABETIC AGENT; VASODILATOR AGENT; VASOPRESSIN ANTAGONIST;

ACUTE CORONARY SYNDROME; ACUTE HEART FAILURE; ACUTE HEART FAILURE SYNDROME; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR RISK; CLINICAL FEATURE; CLINICAL TRIAL; CORONARY VEIN; DIAGNOSTIC TEST; DIASTOLE; DYSPNEA; ECHOCARDIOGRAPHY; FLUID INTAKE; HEART DISEASE; HEART HEMODYNAMICS; HEART INFARCTION; HEART LEFT VENTRICLE FILLING PRESSURE; HEART MUSCLE ISCHEMIA; HEART VENTRICLE OVERLOAD; HOSPITAL ADMISSION; HOSPITAL READMISSION; HUMAN; HYPERTENSION; LUNG CAPILLARY PRESSURE; LUNG CONGESTION; LUNG EDEMA; MYOCARDITIS; NON INVASIVE MEASUREMENT; PATHOPHYSIOLOGY; PATIENT ASSESSMENT; PERIPHERAL EDEMA; PLASMA VOLUME; PRIORITY JOURNAL; PROGNOSIS; SIDE EFFECT; SODIUM INTAKE; SODIUM RETENTION; SYSTOLIC BLOOD PRESSURE; TACHYCARDIA; TREATMENT OUTCOME; VEIN BLOOD FLOW; WATER RETENTION; WEIGHT REDUCTION;

ACUTE DISEASE; BLOOD PRESSURE; BLOOD VOLUME; DYSPNEA; EDEMA; HEART FAILURE; HOSPITALIZATION; HUMANS; PROGNOSIS; SYNDROME; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR REMODELING; WATER-ELECTROLYTE BALANCE;

EID: 33751059230     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2006.09.011     Document Type: Article

References (50)

1. Gheorghiade M., De Luca L., Fonarow G.C., Filippatos G., Metra M., and Francis G.S. Pathophysiologic targets in the early phase of acute heart failure syndromes. Am J Cardiol 96 suppl (2005) 11G-17G
2. Gheorghiade M., Zannad F., Sopko G., et al., International Working Group on Acute Heart Failure Syndromes. Acute heart failure syndromes: current state and framework for future research. Circulation 112 (2005) 3958-3968
3. ADHERE™ Scientific Advisory Committee, and Fonarow G.C. The Acute Decompensated Heart Failure National Registry (ADHERE™): opportunities to improve care of patients hospitalized with acute decompensated heart failure. Rev Cardiovasc Med 4 suppl 7 (2003) S21-S30
4. Publication Committee for the VMAC [Vasodilatation in the Management of Acute CHF] Investigators. Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial. JAMA 287 (2002) 1531-1540
5. Kozak L.J., Owings M.F., Hall M.J., and National Center for Health Statistics. National Hospital Discharge Survey: 2002 annual summary with detailed diagnosis and procedure data. Vital Health Stat 13 158 (2005) 1-199
6. Thom T., Haase N., Rosamond W., et al. Heart Disease and Stroke Statistics-2006 Update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 113 (2006) e85-e151 [published correction appears in Circulation. 2006;113:e696]
7. Haldeman G.A., Croft J.B., Giles W.H., and Rashidee A. Hospitalization of patients with heart failure: National Hospital Discharge Survey, 1985 to 1995. Am Heart J 137 (1999) 352-360
8. Cleland J.G., Swedberg K., Follath F., et al. The EuroHeart Failure survey programme-a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. Eur Heart J 24 (2003) 442-463
9. Cuffe M.S., Califf R.M., Adams K.F.J., et al., Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) Investigators. Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial. JAMA 287 (2002) 1541-1547
10. Gattis W.A., and O'Connor C.M. Predischarge initiation of carvedilol in patients hospitalized for decompensated heart failure. Am J Cardiol 93 suppl (2004) 74B-76B
11. Gheorghiade M., Gattis W.A., O'Connor C.M., et al., Acute and Chronic Therapeutic Impact of a Vasopression Antagonist in Congestive Heart Failure (ACTIV in CHF) Investigators. Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trial. JAMA 291 (2004) 1963-1971
12. O'Connell J.B. The economic burden of heart failure. Clin Cardiol 23 suppl III (2000) III-6-III-10
13. Adams Jr. K.F., Fonarow G.C., Emerman C.L., et al., ADHERE Scientific Advisory Committee and Investigators. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Failure National Registry (ADHERE). Am Heart J 149 (2005) 209-216
14. Fonarow G.C., Abraham W.T., Albert N.M., et al. Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF): rationale and design. Am Heart J 148 (2004) 43-51
15. Tavazzi L., Maggioni A.P., Lucci D., et al. Nationwide survey on acute heart failure in cardiology ward services in Italy. Eur Heart J 27 (2006) 1207-1215
16. Nohria A., Tsang S.W., Fang J.C., et al. Clinical assessment identifies hemodynamic profiles that predict outcomes in patients admitted with heart failure. J Am Coll Cardiol 41 (2003) 1797-1804
17. Mahdyoon H., Klein R., Eyler W., Lakier J.B., Chakko S.C., and Gheorghiade M. Radiographic pulmonary congestion in end-stage congestive heart failure. Am J Cardiol 63 (1989) 625-627
18. Adamson P.B., Magalski A., Braunschweig F., et al. Ongoing right ventricular hemodynamics in heart failure: clinical value of measurements derived from an implantable monitoring system. J Am Coll Cardiol 41 (2003) 565-571
19. Stevenson L.W., and Perloff J.K. The limited reliability of physical signs for estimating hemodynamics in chronic heart failure. JAMA 261 (1989) 884-888
20. Lucas C., Johnson W., Hamilton M.A., et al. Freedom from congestion predicts good survival despite previous class IV symptoms of heart failure. Am Heart J 140 (2000) 840-847
21. Drazner M.H., Rame J.E., Stevenson L.W., and Dries D.L. Prognostic importance of elevated jugular venous pressure and a third heart sound in patients with heart failure. N Engl J Med 345 (2001) 574-581
22. Fonarow G.C., Stevenson L.W., Steimle A.E., et al. Persistently high left ventricular filling pressures predict mortality despite angiotensin converting enzyme inhibition in advanced heart failure. Circulation 90 pt 2 (1994) I-488 Abstract 2624
23. Binanay C., Califf R.M., Hasselblad V., et al., ESCAPE Investigators and ESCAPE Study Coordinators. Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial. JAMA 294 (2005) 1625-1633
24. Michalsen A., Konig G., and Thimme W. Preventable causative factors leading to hospital admission with decompensated heart failure. Heart 80 (1998) 437-441
25. Jain P., Massie B.M., Gattis W.A., Klein L., and Gheorghiade M. Current medical treatment for the exacerbation of chronic heart failure resulting in hospitalization. Am Heart J 145 (2003) S3-S17
26. Remes J., Miettinen H., Reunanen A., and Pyörälä K. Validity of clinical diagnosis of heart failure in primary health care. Eur Heart J 12 (1991) 315-321
27. Marcus G.M., Gerber I.L., McKeown B.H., et al. Association between phonocardiographic third and fourth heart sounds and objective measures of left ventricular function. JAMA 293 (2005) 2238-2244
28. Felker G.M., Cuculich P.S., and Gheorghiade M. The Valsalva maneuver: a bedside "biomarker" for heart failure. Am J Med 119 (2006) 117-122
29. Chakko S., Woska D., Martinez H., et al. Clinical, radiographic, and hemodynamic correlations in chronic congestive heart failure: conflicting results may lead to inappropriate care. Am J Med 90 (1991) 353-359
30. Capomolla S., Ceresa M., Pinna G., et al. Echo-Doppler and clinical evaluations to define hemodynamic profile in patients with chronic heart failure: accuracy and influence on therapeutic management. Eur J Heart Fail 7 (2005) 624-630
31. Logeart D., Thabut G., Jourdain P., et al. Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure. J Am Coll Cardiol 43 (2004) 635-641
32. Maisel A.S., Krishnaswamy P., Nowak R.M., et al., Breathing Not Properly Multinational Study Investigators. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 347 (2002) 161-167
33. Gegenhuber A., Mueller T., Dieplinger B., Lenz K., Poelz W., and Haltmayer M. Plasma B-type natriuretic peptide in patients with pleural effusions: preliminary observations. Chest 128 (2005) 1003-1009
34. Wu A.H.B., Smith A., and Apple F.S. Optimum blood collection intervals for B-type natriuretic peptide testing in patients with heart failure. Am J Cardiol 93 (2004) 1562-1563
35. Wu A.H.B., Smith A., Wieczorek S., et al. Biological variation for N-terminal pro- and B-type natriuretic peptides and implications for therapeutic monitoring of patients with congestive heart failure. Am J Cardiol 92 (2003) 628-631
36. Yu C.-M., Wang L., Chau E., et al. Intrathoracic impedance monitoring in patients with heart failure: correlation with fluid status and feasibility of early warning preceding hospitalization. Circulation 112 (2005) 841-848
37. Henry J.P., Gauer O.H., and Sieker H.O. The effect of moderate changes in blood volume on left and right atrial pressures. Circ Res 4 (1956) 91-94
38. Linden R.J. Atrial receptors and heart volumes. Adv Exp Med Biol 381 (1995) 125-134
39. Mulrow P.J., Takagi M., Takagi M., Atarashi K., and Franco-Saenz R. Inhibition of aldosterone secretion by atrial natriuretic peptide. Ann N Y Acad Sci 512 (1987) 438-448
40. Zucker I.H., Gorman A.J., Cornish K.G., and Lang M. Imparied atrial receptor modulation or renal nerve activity in dogs with chronic volume overload. Cardiovasc Res 19 (1985) 411-418
41. Zucker I.H., Share L., and Gilmore J.P. Renal effects of left atrial distension in dogs with chronic congestive heart failure. Am J Physiol 236 (1979) H554-H560
42. Shah M.R., Hasselblad V., Stinnett S.S., et al. Hemodynamic profiles of advanced heart failure: association with clinical characteristics and long-term outcomes. J Card Fail 7 (2001) 105-113
43. Shah M.R., Hasselblad V., Stinnett S.S., et al. Dissociation between hemodynamic changes and symptom improvement in patients with advanced congestive heart failure. Eur J Heart Fail 4 (2002) 297-304
44. Fonarow G.C., Hamilton M.A., Moriguchi J., Creaser J.W., and Rourke D.A. Hemodynamic predictors of clinical outcome in decompensated advanced heart failure. J Card Fail 3 suppl 2 (2001) 13 Abstract 038
45. Abraham W.T., Lowes B.D., Ferguson D.A., et al. Systemic hemodynamic, neurohormonal, and renal effects of a steady-state infusion of human brain natriuretic peptide in patients with hemodynamically decompensated heart failure. J Card Fail 4 (1998) 37-44
46. Johnson W., Omland T., Hall C., et al. Neurohormonal activation rapidly decreases after intravenous therapy with diuretics and vasodilators for class IV heart failure. J Am Coll Cardiol 39 (2002) 1623-1629
47. Pfeffer M.A., and Lamas G.A. Ventricular remodeling following myocardial infarction: experimental and clinical benefits of ACE inhibition. In: Lindpaintner K., and Ganten D. (Eds). The Cardiac Renin-Angiotensin System (1994), Futura Publishing Company, Inc, Armonk, NY 345-358
48. Sutton M.G., and Sharpe N. Left ventricular remodeling after myocardial infarction: pathophysiology and therapy. Circulation 101 (2000) 2981-2988
49. Paradis P., Dali-Youcef N., Paradis F.W., Thibault G., and Nemer M. Overexpression of angiotensin II type I receptor in cardiomyocytes induces cardiac hypertrophy and remodeling. Proc Natl Acad Sci U S A 97 (2000) 931-936
50. Cotter G., Moshkovitz Y., Milovanov O., et al. Acute heart failure: a novel approach to its pathogenesis and treatment. Eur J Heart Fail 4 (2002) 227-234